Status:
COMPLETED
To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence
Lead Sponsor:
Eli Lilly and Company
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Stress Urinary Incontinence
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
This is an on-going study to evaluate the long-term safety and maintenance of effect of duloxetine in patients suffering with stress urinary incontinence.
Eligibility Criteria
Inclusion
- Have had symptoms of SUI for at least 3 months prior to study entry.
- Have urine leakage most often associated with activity (such as coughing, sneezing, exercise).
- Ambulatory and able to use a toilet independently and without difficulty.
- \-
Exclusion
- Subjects who participated or were discontinued from any previous studies investigating duloxetine.
- Use of excluded medications within 14 days prior to study entry or at any time during the study.
- Subjects who currently have or have had a history of urogenital cancer.
Key Trial Info
Start Date :
March 1 2001
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00190632
Start Date
March 1 2001
End Date
April 1 2006
Last Update
January 26 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician
Cleveland, Ohio, United States, 44122